Fundraising FoxGlakolens
Italy, IT · 1 known investors
Find your way into Glakolens
Glakolens develops a non-invasive biosensor platform embedded in a disposable contact lens to enable continuous 24-hour intraocular pressure monitoring for patients at risk of glaucoma and ocular hypertension. The platform comprises a passive sensor on a soft contact lens and a wearable electronic system that wirelessly collects data during clinic-based monitoring sessions.
Investors · 1
ACT Venture Partnerslisted by ACT Venture PartnersAmsterdam · $550K – $1.6M
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountSeedMay 2017Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Glakolens do?
- Glakolens develops a non-invasive biosensor platform embedded in a disposable contact lens to enable continuous 24-hour intraocular pressure monitoring for patients at risk of glaucoma and ocular hypertension. The platform comprises a passive sensor on a soft contact lens and a wearable electronic system that wirelessly collects data during clinic-based monitoring sessions.
- Who are Glakolens's investors?
- Glakolens's investors include ACT Venture Partners.
- Where is Glakolens headquartered?
- Glakolens is headquartered in Italy, IT.